June 8, 2022- Today kicked off the first day of the 2022 Hybrid Alpha-1 National Conference. We were joined by Alphas, friends, family, doctors, researchers and industry partners to kick off the conference on our NEW virtual conference platform.
Attendees had an opportunity to watch the On-Demand sessions in advance of the conference kickoff, visit the various booths in the exhibit hall and chat with the Alpha-1 staff and industry representatives. Resources were made available throughout the platform to include in the briefcase feature and download before leaving the platform.
The conference started with a video featuring Alpha-1 President & CEO Scott Santarella and enthusiastic Alphas encouraging the community to get involved! Our outstanding physician leadership including Dr. Robert “Sandy” Sandhaus, Dr. Jeanine D’Armiento and Dr. Stephen Rennard for the “Alpha-1: Clinical Trials & Drug Development, Alpha-1 Research Registry and Therapeutic Development Network (TDN)” session moderated by Alpha, Richard Lovrich. On-Demand sessions related to this topic can be found on the platform. A special thank you to Dr. Mark Brantly for moderating the Emerging Therapies question and answer session this evening.
Thank you to our Emerging Therapies Session sponsors for the presentations and participation: Arrowhead Pharmaceuticals, Dicerna Pharmaeuticals, Inhibrx, Kamada, Mereo BioPharma Group, Wave Life Sciences and Wave Life Sciences.
There are so many ways to make a difference and get involved in the Alpha-1 community. “The Time is Now”… How are you going to get engaged? Get involved in fundraising while getting your family and friends engaged in Alpha-1 awareness, make your voice heard by being a patient advocate, join the Alpha-1 Research Registry and be a part of the cure, join an Alpha-1 support group and education yourself and others about Alpha-1.
Thank you to our Platinum Sponsors: AlphaNet, CSL Behring, Grifols and Takeda and Silver Sponsors: Accredo and CVS Specialty.
We can’t wait to “see” you tomorrow for Day Two!
